Taro Transition Report For The Three Months Ended March 2012 on Form 20-F Available
HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO, Taro) announced that its Transition Report for the three month period ended March 31, 2012 on Form 20-F, filed with the Securities and Exchange Commission (the SEC) today, is available within the Investor Relations section of Taros website at www.taro.com. Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., Three Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.
Additionally, the report may be accessed on the SECs website at www.sec.gov.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taros website at www.taro.com.
Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001
Source: Taro Pharmaceutical Industries Ltd.Copyright Business Wire 2012